摘要
伯克霍尔德菌属是一个高度多样化的种群,在各种环境和生境中广泛存在。这一种群中,以对广泛的环境条件(包括消毒剂和有机试剂)的适应力而著称,代表着一些最难治疗的感染性亚群。这个亚群包括类鼻疽伯克霍尔德菌,类鼻疽的病原体;鼻疽伯克霍尔德氏菌,类鼻疽的病原体和洋葱伯克霍尔德复合体 (Bcc) 等导致囊纤维化和免疫低下患者的机会性感染。后者病原体本身就是一个由18个不同但密切相关的物种组成的群体。这个群体的适应性允许分子毒力因子大量的选择表达来促进其在多种生境中生存。本文将描述这些与人类感染相关的选择;比较三种病原体且强调其作为候选疫苗的潜在作用。更好的整合伯克霍尔德菌群发病机制和分子毒力因子的相关知识可有利于更有效疫苗的开发。
关键词: 洋葱伯克霍尔德复合体, 鼻疽伯克霍尔德氏菌,类鼻疽伯克霍尔德菌,囊纤维化,鼻疽,类鼻疽,疫苗,毒力。
Current Medicinal Chemistry
Title:Exploiting Molecular Virulence Determinants in Burkholderia to Develop Vaccine Antigens
Volume: 22 Issue: 14
Author(s): William Thomas Casey and Siobhan McClean
Affiliation:
关键词: 洋葱伯克霍尔德复合体, 鼻疽伯克霍尔德氏菌,类鼻疽伯克霍尔德菌,囊纤维化,鼻疽,类鼻疽,疫苗,毒力。
摘要: The Burkholderia genus is a highly diverse group of species that are distributed throughout a wide range of environments and habitats. Among this group, which is remarkable for its adaptability to a wider range of environmental conditions including disinfectants and organic solvents, are a subgroup that represents some of the most difficult to treat infections. This subgroup includes Burkholderia pseudomallei, the causative agent of melioidosis; B. mallei, the causative agent of glanders and B. cepacia complex (Bcc) which causes opportunistic infections in people with cystic fibrosis and immunocompromised patients. The latter pathogen is itself a group of 18 distinct, but, closely related species. The adaptability of this group allows the expression of a rich selection of molecular virulence determinants to facilitate its survival in the diverse habitats that it colonises. This review will describe a selection of these associated with human infection; comparing them across the three pathogens and highlighting their potential roles as vaccine candidates. Better integration of the knowledge on the pathogenesis and molecular determinants of virulence for these Burkholderia spp may allow the development of more efficacious vaccines.
Export Options
About this article
Cite this article as:
William Thomas Casey and Siobhan McClean , Exploiting Molecular Virulence Determinants in Burkholderia to Develop Vaccine Antigens, Current Medicinal Chemistry 2015; 22 (14) . https://dx.doi.org/10.2174/0929867322666150408111304
DOI https://dx.doi.org/10.2174/0929867322666150408111304 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
A Mini-Review on Cardiovascular and Hematological Complications of COVID-19
Coronaviruses Potential Role of Endothelin in Early Vascular Aging
Current Hypertension Reviews ADAM19/Adamalysin 19 Structure, Function, and Role as a Putative Target in Tumors and Inflammatory Diseases
Current Pharmaceutical Design The Role of VE-cadherin in Blood-brain Barrier Integrity Under Central Nervous System Pathological Conditions
Current Neuropharmacology There is a Link Between Erectile Dysfunction and Heart Failure: It could be Inflammation
Current Drug Targets A Novel Treatment Strategy for Sepsis and Septic Shock Based on the Interactions between Prostanoids, Nitric Oxide, and 20-Hydroxyeicosatetraenoic Acid
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry The Relationship between Inflammatory and Oxidative Stress Biomarkers, Atherosclerosis and Rheumatic Diseases
Current Pharmaceutical Design The Epidemiology of Sepsis
Current Pharmaceutical Design Effectiveness of Nasal Continuous Positive Airway Pressure (CPAP) Therapy on Cardiovascular Outcomes in Obstructive Sleep Apnea-Hypopnea Syndrome (OSAHS)
Current Respiratory Medicine Reviews Reactive Oxygen Species in Vascular Wall
Cardiovascular & Hematological Disorders-Drug Targets Cardiac (myo)fibroblast: Novel Strategies for its Targeting Following Myocardial Infarction
Current Pharmaceutical Design Targeting the Endothelial Ca2+ Toolkit to Rescue Endothelial Dysfunction in Obesity Associated-Hypertension
Current Medicinal Chemistry Patient Education and Telemedicine in COPD
Current Respiratory Medicine Reviews Relaxin as a Cardiovascular Drug: A Promise Kept
Current Drug Safety Metabolomics by Imaging; Biochemical-Magnetic Resonance Correlation: What We Learn from Combined Data of Magnetic Resonance Spectroscopy, NMR Spectroscopy, Clinical Chemistry and Tissue Content Analysis? Major Bottlenecks in Diagnosis
Recent Patents on Medical Imaging Emerging Role of Antioxidants in the Protection of Uveitis Complications
Current Medicinal Chemistry Circadian Cycle and Chronotherapeutics: Recent Trend for the Treatment of Various Biological Disorders
Recent Patents on Drug Delivery & Formulation Relation Between Obstructive Sleep Apnea Syndrome and Resistant Hypertension - The Tip of the Iceberg
Current Respiratory Medicine Reviews The General Practitioners Role in Promoting Physical Activity to Older Adults: A Review Based on Program Theory
Current Aging Science The Role of Therapeutic Drugs on Acquired Mitochondrial Toxicity
Current Drug Metabolism